紛美包裝(00468.HK):要約人持股達約97.76% 要約截止
格隆匯2月18日丨紛美包裝(00468.HK)公告,於2025年2月18日下午四時正,已接獲就998,542,911股股份的要約有效接納,佔於本公告日期已發行股份的約70.96%。於完成向要約人轉讓接納股份後,要約人及要約人一致行動人士將合共持有1,375,675,495股股份(佔於本公告日期已發行股份的約97.76%)。
要約人宣佈要約於2025年2月18日下午四時正截止,且並無作出修訂或延期。
緊隨要約截止及待完成轉讓接納股份予要約人後,要約人將持有截至本公告日期已發行股份約97.76%。因此,未能符合上市規則第8.08(1)(d)條項下所規定的標的公司最低公衆持股量(25%)規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.